Thaker GK - Search Results

1

GABAmimetics: a new class of antidepressant agents?

Thaker GK, Moran M, Tamminga CA. Thaker GK, et al. Arch Gen Psychiatry. 1990 Mar;47(3):287-8. doi: 10.1001/archpsyc.1990.01810150087013. Arch Gen Psychiatry. 1990. PMID: 2306168 Clinical Trial. No abstract available.

2

GABA agonist-induced changes in motor, oculomotor, and attention measures correlate in schizophrenics with tardive dyskinesia.

Cassady SL, Thaker GK, Moran M, Birt A, Tamminga CA. Cassady SL, et al. Among authors: thaker gk. Biol Psychiatry. 1992 Aug 15;32(4):302-11. doi: 10.1016/0006-3223(92)90035-x. Biol Psychiatry. 1992. PMID: 1358231 Clinical Trial.

3

Psychiatric morbidity in research volunteers.

Thaker GK, Moran M, Lahti A, Adami H, Tamminga C. Thaker GK, et al. Arch Gen Psychiatry. 1990 Oct;47(10):980. doi: 10.1001/archpsyc.1990.01810220096020. Arch Gen Psychiatry. 1990. PMID: 2222138 No abstract available.

4

Saccadic distractibility in schizophrenic patients with tardive dyskinesia.

Thaker GK, Nguyen JA, Tamminga CA. Thaker GK, et al. Arch Gen Psychiatry. 1989 Aug;46(8):755-6. doi: 10.1001/archpsyc.1989.01810080085012. Arch Gen Psychiatry. 1989. PMID: 2568826 No abstract available.

5

Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine.

Tamminga CA, Gotts MD, Thaker GK, Alphs LD, Foster NL. Tamminga CA, et al. Among authors: thaker gk. Arch Gen Psychiatry. 1986 Apr;43(4):398-402. doi: 10.1001/archpsyc.1986.01800040108015. Arch Gen Psychiatry. 1986. PMID: 2869745 Clinical Trial.

6

Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.

Thaker GK, Tamminga CA, Alphs LD, Lafferman J, Ferraro TN, Hare TA. Thaker GK, et al. Arch Gen Psychiatry. 1987 Jun;44(6):522-9. doi: 10.1001/archpsyc.1987.01800180032006. Arch Gen Psychiatry. 1987. PMID: 3034188 Clinical Trial.

7

Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.

Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT. Tamminga CA, et al. Among authors: thaker gk. Arch Gen Psychiatry. 1992 Jul;49(7):522-30. doi: 10.1001/archpsyc.1992.01820070016003. Arch Gen Psychiatry. 1992. PMID: 1627043

8

Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.

Thaker GK, Nguyen JA, Strauss ME, Jacobson R, Kaup BA, Tamminga CA. Thaker GK, et al. Am J Psychiatry. 1990 Apr;147(4):445-51. doi: 10.1176/ajp.147.4.445. Am J Psychiatry. 1990. PMID: 1969244 Clinical Trial.

9

GABAmimetic treatments for tardive dyskinesia: efficacy and mechanism.

Tamminga CA, Thaker GK, Nguyen JA. Tamminga CA, et al. Among authors: thaker gk. Psychopharmacol Bull. 1989;25(1):43-6. Psychopharmacol Bull. 1989. PMID: 2672071 Review. No abstract available.

10

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.

Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Holcomb HH, et al. Among authors: thaker gk. Am J Psychiatry. 1996 Jan;153(1):41-9. doi: 10.1176/ajp.153.1.41. Am J Psychiatry. 1996. PMID: 8540590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters